Research Topics
Species | M V PaulySummaryAffiliation: University of Pennsylvania Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Valuing reductions in on-the-job illness: 'presenteeism' from managerial and economic perspectivesMark V Pauly
Health Care Systems Department, The Wharton School, University of Pennsylvania, Philadelphia, PA, USA
Health Econ 17:469-85. 2008....- Impact of Maine's Medicaid drug formulary change on non-Medicaid markets: spillover effects of a restrictive drug formularyY Richard Wang
Public Policy Department AstraZeneca Pharmaceuticals, FOC 3 CE 317, 1800 Concord Pike, Wilmington, DE 19850 5437, USA
Am J Manag Care 9:686-96. 2003..Market penetration of HMOs affect physician practice styles for non-HMO patients... - What if technology never stops improving? Medicare's future under continuous cost increasesMark V Pauly
Health Care Systems Department, Wharton School of the University of Pennsylvania, USA
Wash Lee Law Rev 60:1233-50. 2003 - Is health insurance affordable for the uninsured?M Kate Bundorf
Department of Health Research and Policy, Stanford University School of Medicine, Redwood Building, RM 108, Stanford, CA 94305 5405, United States
J Health Econ 25:650-73. 2006..We find that, depending on the definition, health insurance was affordable to between one-quarter and three-quarters of the uninsured in the United States in 2000... 
A randomized, controlled trial of financial incentives for smoking cessationKevin G Volpp
Center for Health Equity Research and Promotion, Philadelphia Veterans Affairs Medical Center, Philadelphia, USA
N Engl J Med 360:699-709. 2009....- Accountable care organizations and kidney disease care: health reform innovation or more same-old, same-old?Mark V Pauly
Health Care Management Department, The Wharton School, University of Pennsylvania, Philadelphia, 19104, USA
Am J Kidney Dis 60:524-9. 2012.... - Competition in medical services and the quality of care: concepts and historyMark V Pauly
Department of Health Care Systems, The Wharton School, University of Pennsylvania, 208 Colonial Penn Center, 3641 Locust Walk, Philadelphia, PA 19104, USA
Int J Health Care Finance Econ 4:113-30. 2004..Overall competition in the hospital industry has declined modestly in recent years, but competition in markets for more generously reimbursed specific services, such as coronary artery bypass grafting, has increased... 
The problems with estimatesMark V Pauly
Department of Health Care Systems, Wharton School, University of Pennsylvania, Room 208, Colonial Penn Center, 3641 Locust Walk, Philadelphia, PA 19104, USA
Milbank Q 81:155-9; discussion 165-7. 2003- Spillovers and vulnerability: the case of community uninsuranceMark V Pauly
Department of Health Care Systems, Wharton School, University of Pennsylvania, Philadelphia, PA, USA
Health Aff (Millwood) 26:1304-14. 2007..The size of such spillover benefits is reduced if the local market is large enough to be segmented based on insurance status... - Risk pooling and regulation: policy and reality in today's individual health insurance marketMark V Pauly
Health Care Systems Department, Wharton School, University of Pennsylvania, Philadelphia, USA
Health Aff (Millwood) 26:770-9. 2007..The effect on risk pooling is small because of the large amount of risk pooling in unregulated individual insurance... - Risks and benefits in health care: the view from economicsMark V Pauly
Health Care Systems, Wharton School, University of Pennsylvania, Philadelphia, USA
Health Aff (Millwood) 26:653-62. 2007.... - Private health insurance in developing countriesMark V Pauly
Health Care Systems Department, Wharton School, University of Pennsylvania, Philadelphia, USA
Health Aff (Millwood) 25:369-79. 2006..The potential efficiency gains from greater use of voluntary private insurance seem large, but there are a number of possible impediments to the emergence of such insurance... - Competition and new technologyMark V Pauly
Department of Health Care Systems, Wharton School, University of Pennsylvania, in Philadelphia, USA
Health Aff (Millwood) 24:1523-35. 2005..Legal impediments, physician resistance, and membership turnover are all possible obstacles. Further thought should be given to making technology policy an explicit dimension of plan competition... - Improving vaccine supply and development: who needs what?Mark V Pauly
University of Pennsylvania, Philadelphia, PA, USA
Health Aff (Millwood) 24:680-9. 2005.... - Means-testing in MedicareMark V Pauly
Health Care Systems Department, Wharton School, University of Pennsylvania, Philadelphia, USA
Health Aff (Millwood) . 2004..It proposes a strategy in which future Medicare beneficiaries with higher incomes will pay for cost-increasing but quality-improving new technology, possibly with prefunding that begins before retirement... - Death spiral or euthanasia? The demise of generous group health insurance coverageMark V Pauly
Department of Health Care Systems, The Wharton School, University of Pennsylvania, Room 208 Colonial Penn Center, 3641 Locust Walk, Philadelphia, PA 19104, USA
Inquiry 44:412-27. 2007.... - How risky is individual health insurance?Mark V Pauly
Health Care Systems Department, Wharton School, at the University of Pennsylvania in Philadelphia, USA
Health Aff (Millwood) 27:w242-9. 2008..We attribute these results to the offsetting effects of high loadings and guaranteed renewability in the individual market... - A general model of the impact of absenteeism on employers and employeesMark V Pauly
Health Care Systems Department, The Wharton School, 3641 Locust Walk, Philadelphia, PA 19104 6218, USA
Health Econ 11:221-31. 2002..In the long run, workers are likely to bear much of the incidence of the costs associated with absenteeism, and therefore be the likely beneficiaries of any reduction in absenteeism... - Analysis & commentary: The trade-off among quality, quantity, and cost: how to make it--if we mustMark V Pauly
Department of Health Care Management, Wharton School, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Health Aff (Millwood) 30:574-80. 2011..Perhaps a little less quality for a lot less money might be acceptable to consumers and taxpayers, as we work to keep medical spending from siphoning off funds required for other needs... - How private, voluntary health insurance can work in developing countriesMark V Pauly
Department of Health Care Management at Wharton School, University of Pennsylvania, in Philadelphia, USA
Health Aff (Millwood) 28:1778-87. 2009..Spending varies by income, so insurance markets should be segmented by income... - Is it time to reexamine the patent system's role in spending growth?Mark V Pauly
Health Care Management Department, Wharton School, University of Pennsylvania, Philadelphia, PA, USA
Health Aff (Millwood) 28:1466-74. 2009..To lower long-run spending growth, it may be necessary to change patent policy by reducing the term of patent life or linking spending growth targets to net benefits from patented products... - Would you like suspenders to go with that belt? An analysis of optimal combinations of cost sharing and managed careM V Pauly
Wharton School, University of Pennsylvania, Philadelphia 19104 6218, USA
J Health Econ 18:443-58. 1999..The model is extended to the case in which provider cost sharing is also used... - 'We aren't quite as good, but we sure are cheap': prospects for disruptive innovation in medical care and insurance marketsMark V Pauly
Department of Health Care Systems at the Wharton School, University of Pennsylvania, in Philadelphia, USA
Health Aff (Millwood) 27:1349-52. 2008..The applicability of this concept is quite limited but, given sufficient changes in framing and regulating, might be helpful in the future... - An efficient employer strategy for dealing with adverse selection in multiple-plan offerings: an MSA exampleM V Pauly
Health Care Systems Department, Wharton School, University of Pennsylvania, Philadelphia 19104 6218, USA
J Health Econ 19:513-28. 2000..The efficiency gains from adding the MSA/catastrophic health insurance plan (CHP) option are positive but small, and the adverse consequences for high risks under an efficient employee premium are also small... - The evolution of health insurance in India and ChinaMark V Pauly
Wharton School, University of Pennsylvania, in Philadelphia, USA
Health Aff (Millwood) 27:1016-9. 2008.... - Moral hazard in insurance, value-based cost sharing, and the benefits of blissful ignoranceMark V Pauly
Health Care Systems Department, The Wharton School, University of Pennsylvania, 3641 Locust Walk, Philadelphia, PA 19104 6218, United States
J Health Econ 27:1407-17. 2008..Value-based cost sharing can be superior to providing information (even if the cost of information is minimal) when patient demands fall short of informed demands. An extended numerical example illustrates these points... - Blending better ingredients for health reformMark V Pauly
Wharton School, University of Pennsylvania, Philadelphia, USA
Health Aff (Millwood) 27:w482-91. 2008.... - Adverse selection and the challenges to stand-alone prescription drug insuranceMark V Pauly
University of Pennsylvania, USA
Front Health Policy Res 7:55-74. 2004.... - Modeling the cost-effectiveness of granulocyte colony-stimulating factor use in early-stage breast cancerJ H Silber
University of Pennsylvania Cancer Center and the Leonard Davis Institute of Health Economics, Department of Pediatrics, School of Medicine, Philadelphia, USA
J Clin Oncol 16:2435-44. 1998..To model the cost-effectiveness (CE) of granulocyte colony-stimulating factor (G-CSF) in early-stage breast cancer when its use is directed to those most in need of the medication... - Insurance incentives for ambulatory surgeryM V Pauly
Wharton School, University of Pennsylvania, Philadelphia 19104
Health Serv Res 27:813-39. 1993..There are other patient and market characteristics, especially the availability of freestanding surgery firms, that do influence the location of surgery... - Should we be worried about high real medical spending growth in the United States?Mark V Pauly
Department of Health Care Systems, Wharton School, University of Pennsylvania, Philadelphia, USA
Health Aff (Millwood) . 2003..Problems are more severe for public-sector spending, for the uninsured, and for those responding to distorted incentives... - The nongroup health insurance market: short on facts, long on opinions and policy disputesMark V Pauly
Health Care Systems Department, Wharton School University of Pennsylvania, Philadelphia, USA
Health Aff (Millwood) . 2002..We conclude that the individual market works acceptably well for about 80 percent of potential buyers, but its performance for the remaining 20 percent of low-income or high-risk persons is controversial... - Insurance and new technology: from hospital to drugstoreP M Danzon
Health Care Systems Department, Wharton School, University of Pennsylvania in Philadelphia, USA
Health Aff (Millwood) 20:86-100. 2001.... - The Medicare mix: efficient and inefficient combinations of social and private health insurance for U.S. elderlyM V Pauly
Health Care Systems Department, Wharton School, University of Pennsylvania, Philadelphia, USA
J Health Care Finance 26:26-37. 2000..Recent Medicare reforms have helped with the first problem, but the second remains to be solved... - From hospital to drugstore: insurance and the shift to outpatient careP M Danzon
University of Pennsylvania, USA
LDI Issue Brief 7:1-4. 2001..examine the shift from inpatient to outpatient care in the last 20 years,and ask two broad questions: to what extent was this shift encouraged by changes in insurance, and to what extent was insurance coverage influenced by this shift?.. - HMO behavior and stock market valuation: what does Wall Street reward and punish?M V Pauly
Health Care Systems Department, The Wharton School, University of Pennsylvania, Philadelphia, USA
J Health Care Finance 28:7-15. 2001..This analysis supports the view that competitive HMO markets best constrain profits to investor-owned firms... - The new Medicare drug benefit: much ado about little?Mark V Pauly
The Wharton School, University of Pennsylvania, Philadelphia, PA, USA
LDI Issue Brief 9:1-6. 2004..It explores the likely effect of the coverage on overall use of and spending for prescription drugs and considers whether any additional use is likely to represent needed care that had been forgone because of a cost barrier... - Access to conventional medical care and the use of complementary and alternative medicineJosé A Pagán
University of Pennsylvania, Philadelphia, USA
Health Aff (Millwood) 24:255-62. 2005.... - Life insurance and breast cancer risk assessment: adverse selection, genetic testing decisions, and discriminationKatrina Armstrong
Department of Medicine, University of Pennsylvania School of Medicine, USA
Am J Med Genet A 120:359-64. 2003..Although fear of insurance discrimination is associated with the decision not to undergo BRCA1/2 testing, there was no evidence of actual insurance discrimination from BRCA1/2 testing... - Short- and long-term mortality after an acute illness for elderly whites and blacksDaniel Polsky
VA Center for Health Equity Research and Promotion, Department of General Internal Medicine, University of Pennsylvania School of Medicine, Wharton School, University of Pennsylvania, Philadelphia, PA 19104, USA
Health Serv Res 43:1388-402. 2008..To estimate racial differences in mortality at 30 days and up to 2 years following a hospital admission for the elderly with common medical conditions... - Is lower 30-day mortality posthospital admission among blacks unique to the Veterans Affairs health care system?Daniel Polsky
VA Center for Health Equity Research and Promotion, Pittsburgh, PA 19104, USA
Med Care 45:1083-9. 2007..However, no studies have directly compared racial differences in mortality within 30 days of hospitalization between the VA and non-VA facilities in the US health care system... - Market reform in New Jersey and quality of care: a cautionary taleKevin G M Volpp
University of Pennsylvania, Philadelphia, Pennsylvania, USA
LDI Issue Brief 8:1-4. 2003..The findings serve as a reminder that cost-constraining reforms may reduce the quality of care, particularly for uninsured and other vulnerable populations... - P4P4P: an agenda for research on pay-for-performance for patientsKevin G Volpp
Center for Health Incentives, Leonard Davis Institute of Health Economics, Wharton School, University of Pennsylvania, USA
Health Aff (Millwood) 28:206-14. 2009..Patient-targeted incentives have great potential, and systematic testing will help determine how they can best be used to improve population health... - Medicare drug coverage and moral hazardMark V Pauly
Department of Health Care Systems, University of Pennsylvania's Wharton School, Philadelphia, USA
Health Aff (Millwood) 23:113-22. 2004..Thus, from the viewpoint of improvements in health, national spending on drugs, or pharmaceutical firm revenues, effects are small. The effects of such programs on Medicare's fiscal future are much more important... - Comprehensive discharge planning and home follow-up of hospitalized elders: a randomized clinical trialM D Naylor
School of Nursing, University of Pennsylvania, Philadelphia 19104, USA
JAMA 281:613-20. 1999.... - 10 myths of the uninsuredMark V Pauly
Wharton School, University of Pennsylvania, Philadelphia, USA
AHIP Cover 45:16-20, 22. 2004 - Competitive behavior in the HMO marketplaceMark V Pauly
Health Care Systems Department, Wharton School, University of Pennsylvania, USA
Health Aff (Millwood) 21:194-202. 2002..Neither the proportion of HMO enrollees in for-profit HMOs nor HMO market penetration was significantly related to profit rates... - First-cycle blood counts and subsequent neutropenia, dose reduction, or delay in early-stage breast cancer therapyJ H Silber
University of Pennsylvania Cancer Center and the Leonard Davis Institute of Health Economics, Department of Pediatrics and Medicine, School of Medicine, Philadelphia, USA
J Clin Oncol 16:2392-400. 1998..This work reports on the construction of a model of neutropenia, dose reduction, or delay that rank-orders patients according to their need for costly supportive care such as granulocyte growth factors... - Conflict and compromise over tradeoffs in universal health insurance plansMark V Pauly
Insurance and Risk Management, Business and Public Policy, and Economics, Wharton School, University of Pennsylvania, USA
J Law Med Ethics 32:465-73. 2004 - Complementary and alternative medicine: personal preference or low cost option?José A Pagán
Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA
LDI Issue Brief 10:1-4. 2004..This Issue Brief summarizes research that evaluates the relationship between CAM use and perceived access to conventional health care... - How health affects small business in South AfricaLi Wei Chao
Population Studies Center, University of Pennsylvania, Philadelphia, PA USA
LDI Issue Brief 12:1-4. 2007..The results bolster the economic case for investing resources in the prevention and treatment of disease in developing countries... - Carrier screening for cystic fibrosis: costs and clinical outcomesD A Asch
Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA
Med Decis Making 18:202-12. 1998.... - Transitions of elders between long-term care and hospitalsMary D Naylor
University of Pennsylvania, Philadelphia, PA, USA
Policy Polit Nurs Pract 10:187-94. 2009.... - Is high and growing spending on cancer treatment and prevention harmful to the United States economy?Mark V Pauly
Health Care Systems Department, The Wharton School, University of Pennsylvania, Philadelphia, PA, USA
J Clin Oncol 25:171-4. 2007 - Market reform in New Jersey and the effect on mortality from acute myocardial infarctionKevin G M Volpp
Center for Health Equity Research and Promotion, Philadelphia Veterans Hospital, and University of Pennsylvania School of Medicine, 19104-6021, USA
Health Serv Res 38:515-33. 2003..A relative decrease in the use of cardiac procedures in New Jersey may partly explain this finding. Additional studies should be done to identify whether other market reforms have been associated with changes in the quality of care... - Chronic illness, treatment choice and workforce participationRichard A Hirth
Department of Health Policy and Management, University of Michigan School of Public Health, 109 S Observatory, Ann Arbor, MI 48109 2029, USA
Int J Health Care Finance Econ 3:167-81. 2003..However, the effect size is considerably smaller than in models that do not consider the joint nature of these choices... - Keeping health insurance tax credits on the tableMark V Pauly
JAMA 291:2255-6. 2004 - Measuring the effects of work loss on productivity with team productionSean Nicholson
Department of Policy Analysis and Management, Cornell University, Ithaca, NY 14853, USA
Health Econ 15:111-23. 2006..The median multiplier is 1.28, which supports the view that the cost to the firm of missed work is often greater than the wage... - Physicians' career satisfaction, quality of care and patients' trust: the role of community uninsuranceJosé A Pagán
Department of Economics and Finance, College of Business Administration, University of Texas Pan American, Edinburg, TX 78539, USA
Health Econ Policy Law 2:347-62. 2007..Patients in these communities are also less likely to trust their physician... - Guaranteed renewability and the problem of risk variation in individual health insurance marketsVip Patel
eHealthInsurance Inc, Sunnyvale, California, USA
Health Aff (Millwood) . 2002..The paper concludes with a discussion of possible threats to the protection guaranteed renewability provides against risk segmentation... - How to present the business case for healthcare quality to employersSean Nicholson
Cornell University, Ithaca, New York 14853, USA
Appl Health Econ Health Policy 4:209-18. 2005.... - Community-level uninsurance and the unmet medical needs of insured and uninsured adultsJosé A Pagán
Department of Economics and Finance, College of Business Administration, The University of Texas Pan American, 1201 W University Dr, Edinburg, TX 78541, USA
Health Serv Res 41:788-803. 2006..To examine the relationship between community-level uninsurance rates and the self-reported unmet medical needs of insured and uninsured adults in the U.S... - Effect of tiered prescription copayments on the use of preferred brand medicationsThomas S Rector
Center for Health Care Policy and Evaluation, UnitedHealth Group, Eden Prairie, Minnesota 55344, USA
Med Care 41:398-406. 2003..How much this financial incentive affects use of preferred brands has not been widely reported. The aim of this study was to estimate the effect of tiered copayments on the choice between preferred and nonpreferred brand medications... - Incentive-compatible guaranteed renewable health insurance premiumsBradley Herring
Department of Health Policy and Management, Rollins School of Public Health, Emory University, 1518 Clifton Road NE, Atlanta, GA 30322, USA
J Health Econ 25:395-417. 2006..Actual premium paths exhibited by purchasers of individual insurance are close to the optimal renewable schedule we estimate. Finally, consumer utility associated with the feature is examined... - Preventive care in managed care and fee-for-service plans: is it cost effective?Y Richard Wang
Health Services Research and Policy Analysis, Public Policy Department, AstraZeneca Pharmaceuticals, Wilmington, Delaware, USA
Manag Care Interface 16:47-50. 2003..Effective screening strategies must be identified, especially for the underserved, low-income population... - End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF)Avi Dor
George Washington University, School of Public Health and Health Services, Washington, DC, USA
Int J Health Care Finance Econ 7:73-111. 2007..Variation in spending per ESRD patient is relatively small, but correlated with overall per capita health care spending. Remaining differences in costs and outcomes do not seem strongly linked to differences in incentives... - Difference in the use of preventive services between fee-for-service plans and HMOs: is more better?Y Richard Wang
Public Policy Department, AstraZeneca Pharmaceuticals, Wilmington, Del 19850 5437, USA
Am J Manag Care 9:293-301. 2003.... - Getting real performance out of pay-for-performanceSean Nicholson
Cornell University, Ithaca, NY 14853, USA
Milbank Q 86:435-57. 2008..This article offers a paradigm for evaluating how P4P programs should be structured and how effective they are likely to be... - Prescription drug formulary design, preferred-product marketshare, and formulary noncompliance: a study of proton-pump inhibitorsY Richard Wang
Health Services Research and Policy Analysis, Public Policy Department, AstraZeneca Pharmaceuticals, Wilmington, Delaware 19850 5437, USA
Manag Care Interface 18:39-45. 2005..They found that although drug formulary restrictiveness increases the use of preferred products, it also leads to a high level of formulary noncompliance. The net financial effect on drug spending is ambiguous... - Spillover effects of restrictive drug formularies: a case study of PacifiCare in CaliforniaY Richard Wang
Public Policy Department, AstraZeneca Pharmaceuticals, Wilmington, Del 19850 5437, USA
Am J Manag Care 11:24-6. 2005..A restrictive drug formulary may influence how physicians treat other, unaffiliated patients, a phenomenon known as the "spillover effect." In a previous study we found significant spillover effects from Maine's Medicaid formulary...
Research Grants
- Impact of Poor Health & AIDS on Small Businesses in SAMark Pauly; Fiscal Year: 2003..They will be useful for predicting the effect of changes in health on economic activity in this sector, and for allocating resources for disease prevention and treatment. ..